2 Information about rivaroxaban

Information about rivaroxaban

Marketing authorisation indication

Rivaroxaban (Xarelto, Bayer), co-administered with aspirin, is indicated for 'the prevention of atherothrombotic events in adult patients with coronary artery disease or symptomatic peripheral artery disease at high risk of ischaemic events'.

Dosage in the marketing authorisation

The recommended dosage for rivaroxaban is 2.5 mg taken orally twice daily in combination with a daily dose of 75 to 100 mg aspirin taken orally.


The list price for 56 tablets of rivaroxaban 2.5 mg is £50.40 (company submission). The treatment period is indefinite.

  • National Institute for Health and Care Excellence (NICE)